GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neuland Laboratories Ltd (BOM:524558) » Definitions » Gross Margin %

Neuland Laboratories (BOM:524558) Gross Margin % : 53.24% (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Neuland Laboratories Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Neuland Laboratories's Gross Profit for the three months ended in Mar. 2024 was ₹2,050 Mil. Neuland Laboratories's Revenue for the three months ended in Mar. 2024 was ₹3,850 Mil. Therefore, Neuland Laboratories's Gross Margin % for the quarter that ended in Mar. 2024 was 53.24%.


The historical rank and industry rank for Neuland Laboratories's Gross Margin % or its related term are showing as below:

BOM:524558' s Gross Margin % Range Over the Past 10 Years
Min: 33.08   Med: 39.85   Max: 52.92
Current: 52.92


During the past 13 years, the highest Gross Margin % of Neuland Laboratories was 52.92%. The lowest was 33.08%. And the median was 39.85%.

BOM:524558's Gross Margin % is ranked better than
61.26% of 986 companies
in the Drug Manufacturers industry
Industry Median: 46.51 vs BOM:524558: 52.92

Neuland Laboratories had a gross margin of 53.24% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Neuland Laboratories was 9.80% per year.


Neuland Laboratories Gross Margin % Historical Data

The historical data trend for Neuland Laboratories's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neuland Laboratories Gross Margin % Chart

Neuland Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 35.63 39.75 40.18 48.47 52.92

Neuland Laboratories Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.74 49.42 54.14 54.54 53.24

Competitive Comparison of Neuland Laboratories's Gross Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Neuland Laboratories's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Neuland Laboratories's Gross Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neuland Laboratories's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Neuland Laboratories's Gross Margin % falls into.



Neuland Laboratories Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Neuland Laboratories's Gross Margin for the fiscal year that ended in Mar. 2024 is calculated as

Gross Margin % (A: Mar. 2024 )=Gross Profit (A: Mar. 2024 ) / Revenue (A: Mar. 2024 )
=8247.8 / 15585.805
=(Revenue - Cost of Goods Sold) / Revenue
=(15585.805 - 7337.967) / 15585.805
=52.92 %

Neuland Laboratories's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=2049.9 / 3850.097
=(Revenue - Cost of Goods Sold) / Revenue
=(3850.097 - 1800.199) / 3850.097
=53.24 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Neuland Laboratories  (BOM:524558) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Neuland Laboratories had a gross margin of 53.24% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Neuland Laboratories Gross Margin % Related Terms

Thank you for viewing the detailed overview of Neuland Laboratories's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Neuland Laboratories (BOM:524558) Business Description

Traded in Other Exchanges
Address
Road No. 82, Jubilee Hills, Plot No. 573A-III, Phoenix IVY Building, 11th Floor (5th Office Level), Hyderabad, TG, IND, 500033
Neuland Laboratories Ltd is a manufacturer of active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry's chemistry needs in Hyderabad. Geographically, it derives a majority of revenue from North America and also has a presence in India, Europe, and Rest of the world.

Neuland Laboratories (BOM:524558) Headlines

No Headlines